Post-exposure prophylaxis (PEP) to prevent HIV acquisition has been recommended for
over three decades, but remains underutilised. Over the past decade, clinical trials have …

The HIV epidemic continues to pose a significant burden on the healthcare system. Although
the incidence of annual new infections is decreasing, health disparities persist and most …

HIV prevention with postexposure prophylaxis-in-pocket (PIP) | The BMJ Skip to main content
Intended for healthcare professionals Access provided by Google Indexer Subscribe My …

HIV self-testing (HIVST) increases testing frequency among men who have sex with men
(MSM). However, its impact on sexual risk behaviors is unclear. In a randomized controlled …

Background Effectiveness of HIV postexposure prophylaxis (PEPSE) correlates with speed
of uptake following HIV exposure. Time to first dose has not improved in the UK for over 10 …

Introduction Post‐exposure prophylaxis (PEP) is an efficacious prevention method when
initiated promptly after an HIV exposure. Yet, PEP has been underutilized, even among …

Background HIV post-exposure prophylaxis (PEP) is an evidence-based biomedical HIV
prevention strategy consisting of a 28-day course of highly active antiretroviral therapy after …

Background The effectiveness of post-exposure prophylaxis (PEP) depends on participants
adherence, making it crucial to assess and compare regimen options to enhance human …

Background The HIV infection status among men who have sex with men (MSM) in China is
a cause for concern. Post-exposure prophylaxis (PEP) serves as a highly effective …

Background The efficacy of on-demand HIV pre-exposure prophylaxis (PrEP) for men in sub-
Saharan Africa has not been evaluated, and the on-demand PrEP dosing requirement for …